Indeed, administration of ACVR2B/Fc, a synthetic decoy peptide and inhibitor of the signaling downstream of the binding of TGFβ family ligands to the activin receptor type 2B was able to potently preserve muscle mass and prolong survival in a model of cancer cachexia (35). Here, ACVR2B is linked to cancer.